GraftLife AB
559194-2163ActiveDeveloping patented ex-vivo perfusion technology to increase transplantable kidneys globally.
Overview
- 4
- Employees
- 813K SEK
- Revenue
- 2019
- Founded
Key Decision Makers
Magnus Nilsson
CEO
Description
UGLK Science AB is a Swedish biotechnology company focused on solving the critical shortage of transplantable donor kidneys. They have developed a patented ex-vivo kidney perfusion system designed for the reconditioning and evaluation of organs. This innovative system comprises a durable perfusion m...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559194216301
Decision Makers
1 contacts in FunnelfeedrMagnus Nilsson
CEO
Similar Companies
20 similar companies in FunnelfeedrVitrosorb AB
5–9 employeesSwedish medical device company solving organ transplant barriers.
Vitrosorb Technology AB
Swedish medical device company solving critical healthcare needs via apheresis.
Xvivo Perfusion Aktiebolag
50–99 employeesWorld leader developing technology to extend organ life for transplantation.
Carnamedica AB
0 employeesPolish company providing specialized organ perfusion technology for transplant teams.
GLYCOREX TRANSPLANTATION AB (PUBL)
10–19 employeesDevelops technology to remove blood antibodies for transplants and disease.
Browse More
GraftLife AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo